Vol.23 No.2
Published: 11.07.2023.
Authors in this issue:
Abdella M Habib, Abdul-Badi Abou-Samra, Aleksandra Aracki Trenkić, Angela Pia Cazzolla, Atalla Hammouda, Benjie Xu, Boris Zec, Cheng Rao, Chenwei Li, Chunyue Feng, Dan Li, Dejan Nesic, Domenico Ciavarella, Dominik Vilímek, Dragan Stojanov, Eleonora Lo Muzio, Elina Beleva, Fang Li, Fei Liu, Feng Wang, Francesca Di Serio, Francesca Spirito, Gaofei Cao, Gordana Petrovic, Haibo Lu, Hao Jiang, Haowen Pang, Hongbing Ma, Hua Yang, Ivanka Nenova, Jan Malůš, Jaroslav Uchytil, Jianguang Shi, Jiayue Shao, Jie Gong, Jie Lian, Jieqiu Zhang, Jieyun Huang, Jin Li, Jun Wang, Justin Clark, Kai Sun, Lichun Wei, Lina Zhao, Ling-Yu Long, Lishuang Wang, Liu Shi, Lorenzo Lo Muzio, Lucia Varraso, Luigi Santacroce, Luka Nikolic, Marek Bužga, Maria Pepe, Mario Dioguardi, Matej Pekař, Mei Shi, Mengyao Zhang, Michele Di Cosola, Milica Radovanović, Milica Živanović, Miroslav Mišić, Mohan Dong, Moustapha Hamdi, Nan Xu, Omran A H Musa, Pavol Holéczy, Petr Kutáč, Qian Jiang, Qian Zhang, Qiong Qing, Quan-Bing Zhang, Ren Wang, Renato Contino, Roberto Lovero, Rui Zhang, Run Zhang, Saif Badran, Sanja Ninic, Sara Alharami, Sasa Popovic, Semir Vranic, Sergej Prijic, Shigao Huang, Shuli Tang, Siqi Liu, Snezana Ristic, Snezhana Stoencheva, Srdjan Pasic, Stasa Krasic, Suhail A Doi, Tanya Deneva, Veronika Horká, Vito Crincoli, Vladislav Vukomanovic, Vuk Milošević, Vukota Radovanović, Weijie Wu, Weiwei Li, Wen-Min Chen, Wudong Wang, Xiangyi Pang, Xiao-Jun Huang, Xiaopeng Yao, Xiaoxiao Liu, Xin Wang, Xinjian Li, Xu Wang, Xuejing Zhong, Ya-Zhen Qin, Yanhui Chen, Ying Zhang, Yingying Jin, Yongrong Zhang, Yuchen Wang, Yun Zhou, Zdeněk Švagera, Zhanet Grudeva-Popova, Zhenjing Jin, Zishan Wang,
Edited by:
Muzafer Mujic & Semir Vranic
Author guidelines
Editorial Policy
4
Issues23
ArticlesYour first address
𝐁𝐢𝐨𝐦𝐨𝐥𝐞𝐜𝐮𝐥𝐞𝐬 𝐚𝐧𝐝 𝐁𝐢𝐨𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 (formerly 𝐁𝐉𝐁𝐌𝐒) is the first address for discoveries in the field of biomedical research.
Become guest editor
Special Issues are led by Guest Editors who are experts in the subject and oversee the editorial process for papers.
Editor’s choice articles
The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Archive
See all
Volume 23, Issue 2, 2023
Volume 23, Issue 2, 2023
Volume 15, Issue 1,
Volume 14, Issue 1,
- All Sections
- Biochemistry
- Molecular Biology
- Pathology
- Anatomy
- Translational and Clinical Research
- New and Emerging Medical Entities
16.03.2023.
Editorial
Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
Semir Vranic
16.03.2023.
Research article
Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis
Interleukin 35 (IL-35) mediates immunosuppression of T cells in autoimmune diseases. T cells play an important role in primary biliary cholangitis (PBC) with incompletely elucidated pathogenesis. Thus, we aimed to investigate the role of IL-35 regulation on T cells in PBC patients. Fifty-one PBC patients and 28 controls were enrolled in this study. Plasma IL-35 level was measured. Purified peripheral CD4+ and CD8+ T cells were stimulated with exogenous IL-35 to investigate their functional phenotypes. IL-35-treated CD8+ T cells were cultured with human intrahepatic biliary epithelial cell line to determine the cytotoxicity of CD8+ T cells from PBC patients. Plasma IL-35 concentration was lower in PBC patients and negatively correlated with alkaline phosphatase. CD4+ T cells from PBC patients exhibited elevated transcription factor expressions and cytokine secretion, whereas CD8+ T cells produced increased cytotoxic molecules and cytokines. In vitro IL-35 stimulation suppressed the production of IL-17 and IL-22 by CD4+ T cells from PBC patients. CD8+ T cells treated with IL-35 mediated reduced target cell death in the direct contact co-culture system in PBC patients. This process was accompanied by reduced production of cytotoxic molecules and cytokines and increased expressions of immune checkpoint receptors in CD8+ T cells. Reduced circulating IL-35 might be insufficient to suppress T cell function, leading to the immune dysregulation in PBC patients.
Siqi Liu, Qian Zhang, Mengyao Zhang, Xuejing Zhong, Wudong Wang, Lishuang Wang, Zhenjing Jin